Elsevier

Antiviral Research

Volume 88, Issue 2, November 2010, Pages 176-181
Antiviral Research

Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases γ and β by thiated 3′-fluorothymidine analogue 5′-triphosphates

https://doi.org/10.1016/j.antiviral.2010.08.011Get rights and content

Abstract

3′-Deoxy-3′-fluorothymidine (FLT, alovudine®) belongs to the most potent agents inhibiting HIV-1 replication. Its 5′-triphosphate (FLTTP) is a potent inhibitor of HIV-1 reverse transcriptase (HIV RT). Unfortunately, FLT exerts substantial hematologic toxicity both in vitro and in vivo. It was suggested that this toxicity may be related to inhibition of human DNA polymerases, especially mitochondrial DNA polymerase γ, by nucleoside analogue 5′-triphosphates leading to termination of DNA synthesis and mitochondrial dysfunction. To decrease the toxicity of FLT, its thiated analogues, 4-SFLT and 2-SFLT, were previously synthesized and shown to be potent inhibitors of HIV-1 with low in vitro cytotoxicity. To explain this phenomenon in the present study the synthesis of 5′-triphosphates of thiated FLT analogues was undertaken and their interaction with recombinant HIV-1 RT and human DNA polymerases γ (pol γ) and β (pol β) was investigated. It was shown that 3′-deoxy-3′-fluoro-4-thiothymidine 5′-triphosphate (4-SFLTTP) and 3′-deoxy-3′-fluoro-2-thiothymidine 5′-triphosphate (2-SFLTTP) were, similarly to FLTTP, potent competitive inhibitors of HIV-1 RT, with Kiapp values of 0.091 and 0.022 μM respectively. It is of interest that 2-SFLTTP, a compound in an unusual syn conformation around the glycosidic bond was an uncompetitive inhibitor of human mitochondrial DNA pol γ with Kiapp of 0.174 μM, while 4-SFLTTP in anti conformation inhibited this enzyme similarly to FLTTP, i.e., non-competitively, with Kiapp of 0.055 μM. Both 4-SFLTTP and 2-SFLTTP were competitive inhibitors of human DNA pol β, with Kiapp values of 16.84 and 4.04 μM, respectively. The results point to partially selective inhibition of HIV RT by thiated 3′-fluorothymidine 5′-triphosphate analogues. Of special interest is that 2-SFLTTP, showing syn conformation, is a less potent inhibitor of human mitochondrial pol γ than 4-SFLTTP and FLTTP, both in the anti conformation, and has a higher inhibitory activity against HIV-1 RT than 4-SFLTTP. Moreover, the parent nucleoside 2-SFLT possessing the syn conformation shows a more potent anti-HIV-1 activity and a better selectivity index than its 4-thio isomer in the anti conformation (Matthes et al., 1989, Poopeiko et al., 1995), 2-SFLT is a potent and selective anti-HIV-1 agent with the selectivity index 4-fold higher than that of FLT.

Findings regarding the mechanisms of antiviral and cytotoxic activities of FLT and its thioanalogues are discussed.

Introduction

Multidrug, highly active antiretroviral therapy (HAART) employed in the treatment of human immunodeficiency virus (HIV) infection uses as its main components nucleoside inhibitors of HIV reverse transcriptase (NRTIs). It was suggested that long term therapy with the NRTIs may be associated with mitochondrial DNA polymerase γ (pol γ) inhibition and subsequent depletion of mitochondrial DNA (Kaguni, 2004, Kakuda, 2000). However, the DNA pol γ hypothesis by itself fails to explain the entire array of metabolic deficiencies associated with NRTI-induced disorders. Direct effects of NRTI's on various mitochondrial targets must also be taken into account (Lund and Wallace, 2004).

3′-Deoxy-3′-fluorothymidine (FLT, alovudine®) belongs to the most potent agents inhibiting HIV-1 replication. In addition, it is highly active against HIV-1 multidrug resistant (MDR) strains. Its 5′-triphosphate (FLTTP) is a potent inhibitor of HIV-1 reverse transcriptase (HIV RT, RNA-directed DNA polymerase, EC 2.7.7.49) (Cheng et al., 1987). Unfortunately, FLT displays high cytotoxicity against host cells which limits its clinical applicability (Balzarini et al., 1988). It was suggested that this toxicity may be related to inhibition of human DNA polymerases (EC 2.7.7.7), especially mitochondrial DNA polymerase γ, by FLT metabolite—5′-triphosphate, leading to termination of DNA synthesis and mitochondrial dysfunction (Kaguni, 2004). To decrease the cellular toxicity of FLT, its thiated analogues 4-SFLT and 2-SFLT were previously prepared and shown to be potent in vitro inhibitors of HIV-1 with low toxicity (Matthes et al., 1989, Poopeiko et al., 1995). To establish whether inhibition of pol γ exerted by thiated FLTTP analogues is correlated with development of in vitro cytotoxicity in cell cultures, we decided to synthesise 2-SFLTTP, 4-SFLTTP as well as FLTTP and to investigate their interactions with recombinant HIV-1 RT and human polymerases γ and β.

Section snippets

Chemicals

[Methyl-3H] dTTP (45.9 Ci/mmol) was purchased from Moravek Biochemicals Inc., Brea, CA; nucleotides and activated calf thymus DNA were from Sigma; AZTTP was purchased from Calbiochem; poly(rA)·p(dT)12–18 and HIV reverse transcriptase were from GE Healthcare (Amersham Biosciences); DE81 (2.3 cm) circles were from Whatman. Triton X-100 and rotiszint eco plus LSC-universal cocktail were from Roth. Recombinant human DNA polymerases γ and β were provided by EURx Ltd. (Gdańsk, Poland). All other

Kinetics of incorporation of dTMP

The rates of dTMP incorporation into poly(rA)·p(dT)12–18 by HIV-1 RT and human DNA polymerase γ and into activated DNA by human DNA pol β were linear with respect to time and enzyme concentration with Vmaxapp values of 370 ± 99, 0.23 ± 0.05 and 64 ± 15 nmol min−1 mg−1 protein, respectively; the template–primer concentrations used in the assays did not inhibit the enzyme activity (Majumdar et al., 1988). The Kmapp value obtained for dTTP for HIV-1 RT (9.05 ± 0.46 μM) was similar to the values determined by

Conclusions

The presented results show that both 4-SFLTTP and 2-SFLTTP are potent, competitive inhibitors of HIV-1 RT. On the other hand, their parent nucleosides, 4-SFLT and 2-SFLT exert reduced, in comparison to FLT, anti-HIV-1 activity as well as cytotoxicity, in spite of the high inhibitory activities of their 5′-triphosphates against human polymerase γ (Table 1). Anti-HIV-1 RT inhibitory activities of 5′-triphosphates of both thiated nucleoside analogues only partially correlated with the antiviral

Acknowledgment

This project was supported by EC grant LSHP-CT-2007-037760.

References (41)

  • E. Matthes et al.

    Inhibition of HIV-associated reverse transcriptase by sugar-modified derivatives of thymidine 5′-triphosphate in comparison to cellular DNA polymerases alpha and beta

    Biochem. Biophys. Res. Commun.

    (1987)
  • E. Matthes et al.

    Inhibition of HIV-replication by 3′-fluoro-modified nucleosides with low cytotoxicity

    Biochem. Biophys. Res. Commun.

    (1989)
  • W.B. Parker et al.

    Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase and human DNA polymerases alpha, beta, and gamma by the 5′-triphosphates of carbovir, 3′-azido-3′-deoxythymidine, 2′,3′-dideoxyguanosine, and 3′-deoxyguanosine

    J. Biol. Chem.

    (1991)
  • J. Poznański et al.

    1H NMR conformational study of antiherpetic C5-substituted 2′-deoxyuridines: insight into the nature of structure–activity relationships

    Biochem. Biophys. Res. Commun.

    (2000)
  • J.E. Reardon et al.

    Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5′-triphosphate and 3′-azido-3′-deoxythymidine 5′-triphosphate

    J. Biol. Chem.

    (1990)
  • R.A. Steet et al.

    3′-Azidothymidine potently inhibits the biosynthesis of highly branched N-linked oligosaccharides and poly-N-acetyllactosamine chains in cells

    J. Biol. Chem.

    (2000)
  • L. Vrang et al.

    Inhibition of the reverse transcriptase from HIV by 3′-azido-3′-deoxythymidine triphosphate and its threo analogue

    Antiviral Res.

    (1987)
  • G. Yang et al.

    Highly selective action of triphosphate metabolite of 4′-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT

    Antiviral Res.

    (2007)
  • J. Balzarini et al.

    Halogeno-3′-fluoro-2′,3′-dideoxyuridines as inhibitors of human immunodeficiency virus (HIV): potent and selective anti-HIV activity of 3′-fluoro-2′,3′-dideoxy-5-chlorouridine

    Mol. Pharmacol.

    (1989)
  • F. Becher et al.

    Significant levels of intracellular stavudine triphosphate are found in HIV-infected zidovudine-treated patients

    AIDS

    (2003)
  • Cited by (4)

    • Thiated derivatives of 2',3'-dideoxy-3'-fluorothymidine: Synthesis, in vitro anti-HIV-1 activity and interaction with recombinant drug resistant HIV-1 reverse transcriptase forms

      2011, Antiviral Research
      Citation Excerpt :

      The results obtained for the thiated FLTMP analogues 11, 12 and 13 point to a more important role of 4-thio- than 2-thio- or 2,4-dithio-substituents in the thymine moiety of FLTMP in enhancing the antiviral activity without increase in cytotoxicity in the deCIPhR assay (Table 2). This may be related to the closer steric analogy to FLTMP of S4FLTMP (12) (conformation anti) than those of S2FLTMP (11) and S2,4FLTMP (13) (conformations syn) congeners (Wińska et al., 2010). Antiviral activity of FLTMP (14) is similar or several times less (some mutant strains) than that of FLT.

    View full text